Investment analysts at Truist Financial started coverage on shares of Intuitive Surgical (NASDAQ:ISRG – Get Rating) in a report issued on Tuesday, The Fly reports. The brokerage set a “buy” rating on the medical equipment provider’s stock.
Several other research firms have also commented on ISRG. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Intuitive Surgical from $323.00 to $300.00 and set a “hold” rating on the stock in a report on Friday, January 21st. Piper Sandler upgraded Intuitive Surgical from a “neutral” rating to an “overweight” rating and increased their target price for the company from $300.00 to $310.00 in a report on Monday, January 31st. The Goldman Sachs Group upgraded Intuitive Surgical from a “buy” rating to a “conviction-buy” rating in a research note on Thursday, December 16th. Morgan Stanley dropped their price objective on Intuitive Surgical from $375.00 to $325.00 and set an “equal weight” rating on the stock in a research note on Friday, January 21st. Finally, StockNews.com began coverage on Intuitive Surgical in a report on Thursday, March 31st. They issued a “hold” rating for the company. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Buy” and an average target price of $331.44.
Shares of Intuitive Surgical stock traded down $12.01 on Tuesday, reaching $277.85. 1,137,836 shares of the stock were exchanged, compared to its average volume of 2,084,896. The business has a fifty day moving average price of $287.34 and a two-hundred day moving average price of $322.15. The firm has a market capitalization of $99.80 billion, a PE ratio of 59.54, a PEG ratio of 7.38 and a beta of 1.17. Intuitive Surgical has a 1-year low of $254.20 and a 1-year high of $369.69.
In other news, EVP Myriam Curet sold 2,478 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 16th. The shares were sold at an average price of $289.00, for a total transaction of $716,142.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 1,410 shares of the stock in a transaction that occurred on Tuesday, January 25th. The stock was sold at an average price of $261.64, for a total value of $368,912.40. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the stock. Bell Investment Advisors Inc purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $29,000. Allworth Financial LP purchased a new position in Intuitive Surgical in the 3rd quarter valued at about $35,000. Assetmark Inc. boosted its holdings in Intuitive Surgical by 585.7% in the 3rd quarter. Assetmark Inc. now owns 48 shares of the medical equipment provider’s stock worth $48,000 after buying an additional 41 shares during the last quarter. Atwood & Palmer Inc. acquired a new position in shares of Intuitive Surgical during the third quarter valued at approximately $56,000. Finally, Hexagon Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 200.0% in the fourth quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 46 shares during the last quarter. Institutional investors own 44.03% of the company’s stock.
Intuitive Surgical Company Profile (Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- Greenbrier Companies Stock has Green in its Future
- Insiders Are Selling Palo Alto Networks
- Headwinds Mount For Carmax, Don’t Count On Higher Share Prices
- Tilray Stock Has Better Days Ahead
- 3 Bank Stocks That Are Ready to Handle Whatever the Fed Throws at Them
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.